Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 6,401

Document Document Title
WO/2009/107853
An agent for preventing or ameliorating skin aging, which exhibits a more excellent effect on the suppression of formation, or the amelioration, of wrinkles on the skin or sagging skin. An agent for preventing or ameliorating skin aging,...  
WO/2009/108680
Exemplary embodiments of this invention encompass a method for degrading rebaudioside A and the rebaudioside A derivative products derived therefrom. In particular, this invention relates to a method for degrading rebaudioside A composit...  
WO/2009/108680
Exemplary embodiments of this invention encompass a method for degrading rebaudioside A and the rebaudioside A derivative products derived therefrom. In particular, this invention relates to a method for degrading rebaudioside A composit...  
WO/2009/101213
The present invention relates to an enzyme called chitinosanase which is obtained from the fungus Alternaria alternate, said enzyme breaking down chitosane and specifically cleaving the glycosidic GIcNAc-GIcN bond in chitosane, DNA seque...  
WO/2009/102928
The invention provides compounds and methods for making adenosine-ribofuranoside tetraphosphate compounds. The compounds are contemplated to have activity at the P2Y receptor and may be used in the treatment of medical disorders such as ...  
WO/2009/102736
The invention disclosed in this document is related to the field of pesticides and their use in controlling pests. A compound having the following structure is disclosed.  
WO/2009/098400
The invention relates to a chemical compound of the disaccharide type of the following general formula (A): where, Z = O or S; X1 = azido or NHCOR3 where R3 = 1 -5 c alkyl or aryl, X2 = benzyl, H or sulfonate, X3 = -CH2φ, -CHφ forming ...  
WO/2009/095588
The invention relates to compounds of the formula (I) in which: R1 = OH or NH2; OR2, OR3, OR4 and OR5 form alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate functions; and if R5 = H, if R2 =R3=R4, then R2, R3 and R4 ...  
WO/2009/095588
The invention relates to compounds of the formula (I) in which: R1 = OH or NH2; OR2, OR3, OR4 and OR5 form alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate functions; and if R5 = H, if R2 =R3=R4, then R2, R3 and R4 ...  
WO/2009/097596
The present disclosure provides compositions and methods for the treatment and elimination of chronic intracellular infections in cells or organisms. The compositions may include one or more acidic substances and one or more antimicrobia...  
WO/2009/096503
Disclosed is a compound having a novel structure, few adverse side effects and an excellent inhibitory activity on human SGLT1 and/or SGLT2, or a hydrate of the compound. Also disclosed is a pharmaceutical composition for treating and/or...  
WO/2009/093604
This object aims to provide an organic nanotube manufacturing method and an organic nanotube manufacturing device that pressurize an organic nanotube material dispersion solution comprised of an organic nanotube material and an organic s...  
WO/2009/086720
2,3,4,6-tetra-O-acetyl-D-glucopyranosyl-[N,N'-di-(2-chloroet hyl)]-phosphoric acid diamide I, its α-configuration II and its β-configuration III. These compounds show inhibitory action on transplantation tumors in mouse from the pharma...  
WO/2009/087677
The present invention relates to an improved process for the preparation of 2, 3, 6, 3', 4'- Penta-O-acetylsucrose 6-PAS), formula (V) and sucralose, formula (I).  
WO/2009/088618
A method for the aralkylation of anthracyclins by utilizing an aralkylating agent R3-CH2X (for example, BnBr) in accordance with the reaction pathway describe by the scheme shown in Fig. 1. The present invention recognizes that 4-R1, 3'-...  
WO/2009/080215
Suggested are alkylene oxide adducts of oligosaccharides, obtainable in that an aqueous solution of at least one water-soluble oligosaccharide is subjected to alkoxylation within a temperature range of 90 to 160 °C.  
WO/2009/081211
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/081211
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/078462
Disclosed is a sugar chain primer represented by the following general formula (I). Lac-O-Ck:m(n) (I) (In the formula (I), Ck represents an alkenyl chain; m represents the total number of double bonds; and n represents the positions of t...  
WO/2009/075186
Disclosed is a method for producing a 4-deoxy-4-fluoro-D-glucose derivative, wherein a D-galactose derivative is reacted with sulfuryl fluoride (SO2F2), trifluoromethanesulfonyl fluoride (CF3SO2F) or perfluorobutanesulfonyl fluoride (C4F...  
WO/2009/068531
The present invention relates to a compound The instant invention relates to a compound of formulae (I A), (I B), (X A), (X B), (Y A) or (Y B), wherein R' represents (formula) and R' represents hydrogen, hydroxy, C1-C7alkoxy, C1-C8-alkan...  
WO/2009/069668
Disclosed is a means which is effective for the treatment of melanoma. Specifically disclosed is an agent for increasing the expression of a malignant melanoma antigen, which comprises a compound selected from the group consisting of met...  
WO/2009/067846
The invention discloses a purifying method of monoglycoside acid which comprises selective oxidizing primary hydroxy group of the monoglycoside, exchanging the reacted composite liquid through an activated strong acid cation exchange res...  
WO/2009/069800
Disclosed are a novel aminoglycoside antibiotic, a production method thereof, and a pharmaceutical use thereof. Specifically disclosed are a compound represented by the formula (I) below, a production method thereof, and a use thereof as...  
WO/2009/066117
The invention relates to the use of ethylenediamine tetraacetic acid (EDTA) and its derivatives, i.e. its salts and complexes for prevention and treatment of bacterial intestinal diseases of pigs and for increasing the effects of antibio...  
WO/2009/067692
Compounds of structure (I): having antibacterial activity are disclosed, including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q3, R8 and R9 are as defined herein. Methods associated with prepar...  
WO/2009/059945
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...  
WO/2009/059945
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...  
WO/2009/060086
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolip...  
WO/2009/060305
The invention provides analogs of alpha-galactosyl ceramide that increase the immune response elicited by various antigens. It also provides methods of using such compounds to increase the effectiveness of vaccines.  
WO/2009/060086
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolip...  
WO/2009/055677
Synthetically-derived S,S-heterodisubstituted disulfides that exhibit potent in vitro antibacterial activity against a variety of bacteria, including Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Francisella tula...  
WO/2009/049428
Particular naturally occurring glycosylated acyl-flavonols, e.g. montbretm A (of the formula below wherein R1, R2, R3, R5, R5', and R7 is OH each, X is β-D-glucopyranosyl), are now shown to be effective mammalian α-amylase inhibitors S...  
WO/2009/049370
The invention relates to novel compounds that have utility as inhibitors of heparan sulfate-binding proteins; compositions comprising the compounds, and use of the compounds and compositions thereof for the antiangiogenic, antimetastatic...  
WO/2009/052088
Fire extinguishing compositions and methods of extinguishing a fire comprising compounds of formula (I) where Rf is a fluorocarbon group. The compounds and compositions described herein are useful as intermediates in the preparation of o...  
WO/2009/048343
The invention relates to methods for effecting qualitative and quantitative changes in the functional moieties expressed at the surface of cells and multi-cellular structures, and functional lipid constructs for use in such methods. In p...  
WO/2009/047792
The invention provides carbohydrate based compounds of formula (I), methods of preparation, and compositions useful for modulating signaling through Toll -like receptors. The methods involve contacting a TLR -express ing cell with a carb...  
WO/2009/047792
The invention provides carbohydrate based compounds of formula (I), methods of preparation, and compositions useful for modulating signaling through Toll -like receptors. The methods involve contacting a TLR -express ing cell with a carb...  
WO/2009/044886
The invention aims to provide a process for producing 1,2,3-tri-O-acetyl-5-deoxyribofuranose by an industrially suitable means. The invention provides a process for the production of 1,2,3-tri-O-acetyl-5-deoxyribofuranse which comprises ...  
WO/2009/038978
Steviol glycoside isomers are provided having the formula (II): wherein R1may be hydrogen, 1-β-D-glucopyranosyl, or 2-(1-β-D-glucopyranosyl)-1-β-D- glucopyranosyl, and R2 may be hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosy...  
WO/2009/036754
The invention relates to a composition having the general structure (formula), wherein R1 is a hydrophobic group, R2 is hydrogen (H), a cation or an alkyl ester, R3 is hydrogen (H) or a group that can be converted into the hydroxy group ...  
WO/2009/038978
Steviol glycoside isomers are provided having the formula (II): wherein R1may be hydrogen, 1-β-D-glucopyranosyl, or 2-(1-β-D-glucopyranosyl)-1-β-D- glucopyranosyl, and R2 may be hydrogen, 1-β-D-glucopyranosyl, 2-(1-β-D-glucopyranosy...  
WO/2009/035107
Disclosed is a transformant produced by introducing a keto reductase gene involved in the biosynthesis of L-epivancosamine into a ray fungus originally capable of producing daunorubicin. Also disclosed is a method for efficiently produci...  
WO/2009/030073
Provided is a dTDP-β-D-fucofuranose, which is also referred to as dTDP-β-6-deoxy-D-galactofuranose. The dTDP-β-D-fucofuranose is synthesized by using reductase Fcf1 and mutase Fcf2 in the gram-negative bacteria. Also provided are the ...  
WO/2009/016647
The present invention provides novel pyrrolo[2,1-c][1, 4]benzodiazepine- glycoside prodrug of general formula (1a-b), useful as selective anticancer agents. The present invention also provides a process for the preparation of novel pyrro...  
WO/2009/014101
Disclosed is a sulfoquinovosyl acyl propanediol derivative represented by the general formula (I) or a pharmaceutically acceptable salt thereof. (I) wherein R1 represents an acyl residue of a fatty acid; and M represents a hydrogen ion o...  
WO/2009/014970
Methods of synthesizing sodium glucose co-transporter 2 inhibitors, as well as compounds useful therein, are disclosed. Particular inhibitors are compounds of formula (I).  
WO/2009/004899
It is intended to provide a novel sialidase inhibitor capable of inhibiting the activity of sialidase present in Trypanosoma cruzi or the like. An N-acylneuraminic acid derivative in which an aromatic ring has been introduced at the 9-po...  
WO/2009/005129
Disclosed are: a non-digestible hydroxypropyl starch hydrolysate which can be used as a novel water-soluble dietary fiber; a method for producing the non-digestible hydroxypropyl starch hydrolysate; and a beverage or food comprising the ...  
WO/2008/151615
The invention relates to a method for producing biosurfactants, according to which micro-organisms producing biosurfactants are moved in a nutrient substrate. According to the invention, the nutrient substrate is used in excess and a mec...  

Matches 401 - 450 out of 6,401